JP2001021557A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001021557A5 JP2001021557A5 JP1999197378A JP19737899A JP2001021557A5 JP 2001021557 A5 JP2001021557 A5 JP 2001021557A5 JP 1999197378 A JP1999197378 A JP 1999197378A JP 19737899 A JP19737899 A JP 19737899A JP 2001021557 A5 JP2001021557 A5 JP 2001021557A5
- Authority
- JP
- Japan
- Prior art keywords
- monomer
- buffer
- plasmin
- fibrin
- hybridoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000178 monomer Substances 0.000 description 13
- 108010073385 Fibrin Proteins 0.000 description 5
- 102000009123 Fibrin Human genes 0.000 description 5
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 5
- 108010088842 Fibrinolysin Proteins 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229950003499 fibrin Drugs 0.000 description 5
- 210000004408 hybridoma Anatomy 0.000 description 5
- 229940012957 plasmin Drugs 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000006173 Good's buffer Substances 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 230000020764 fibrinolysis Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000003154 D dimer Substances 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 102000003801 alpha-2-Antiplasmin Human genes 0.000 description 1
- 108090000183 alpha-2-Antiplasmin Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000011095 buffer preparation Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 108010052295 fibrin fragment D Proteins 0.000 description 1
- 239000000282 fibrinogen degradation product Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical group C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229960003766 thrombin (human) Drugs 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19737899A JP3857468B2 (ja) | 1999-07-12 | 1999-07-12 | Ｄダイマー及びｄｄ／ｅ複合体の免疫学的分析方法及び分析用キット |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19737899A JP3857468B2 (ja) | 1999-07-12 | 1999-07-12 | Ｄダイマー及びｄｄ／ｅ複合体の免疫学的分析方法及び分析用キット |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001021557A JP2001021557A (ja) | 2001-01-26 |
| JP2001021557A5 true JP2001021557A5 (enExample) | 2005-06-02 |
| JP3857468B2 JP3857468B2 (ja) | 2006-12-13 |
Family
ID=16373525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19737899A Expired - Lifetime JP3857468B2 (ja) | 1999-07-12 | 1999-07-12 | Ｄダイマー及びｄｄ／ｅ複合体の免疫学的分析方法及び分析用キット |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3857468B2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2275980T3 (es) * | 2002-08-09 | 2007-06-16 | Dade Behring Marburg Gmbh | Combinacion de proteina c reactiva y dimero-d para el diagnostico de trombosis venosa profunda (tvp). |
| JP4589756B2 (ja) * | 2005-02-25 | 2010-12-01 | シスメックス株式会社 | Ｄダイマー測定用キット |
| US7560283B2 (en) * | 2006-01-27 | 2009-07-14 | Bio-Rad Laboratories, Inc. | Storage-stable cellular whole blood composition containing elevated amounts of D-dimer |
| CN107602698A (zh) | 2010-04-01 | 2018-01-19 | 美迪恩斯生命科技株式会社 | 新的单克隆抗体以及d二聚体的免疫学测定方法 |
| JP5709425B2 (ja) | 2010-07-27 | 2015-04-30 | シスメックス株式会社 | Ｄダイマー測定用試薬 |
| EP2599865B1 (en) * | 2010-07-30 | 2017-09-27 | Sysmex Corporation | Anti-fdp monoclonal antibody, fdp measurement reagent and reagent kit using same, and fdp measurement method |
| JP5824568B2 (ja) * | 2014-11-19 | 2015-11-25 | シスメックス株式会社 | Ｄダイマー測定方法 |
-
1999
- 1999-07-12 JP JP19737899A patent/JP3857468B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2554673B1 (en) | Novel monoclonal antibodies and method of immunological analysis of d-dimer | |
| EP0632270A1 (en) | Method of assaying activity of blood coagulation factor xiii and reagent kit therefor | |
| US20090239306A1 (en) | Reference material for assaying d-dimer | |
| Chen et al. | Impaired release of tissue plasminogen activator from the endothelium in Graves' disease—indicator of endothelial dysfunction and reduced fibrinolytic capacity | |
| JPS58154515A (ja) | 組織トロンボプラスチン調製物及びその製法 | |
| WO1995012617A1 (en) | Anti-human soluble fibrin antibody hybridoma, and immunoassaying method | |
| JP2001021557A5 (enExample) | ||
| JPH10509514A (ja) | 止血活性の分析のための方法、試薬およびキット | |
| US4106990A (en) | Quantitative determination of antithrombin III | |
| JP3857468B2 (ja) | Ｄダイマー及びｄｄ／ｅ複合体の免疫学的分析方法及び分析用キット | |
| CA2049710A1 (en) | Assays using a soluble fibrin-like monomer | |
| Soria et al. | Dynamic coronary fibrinolysis evaluation in patients with myocardial infarction and unstable angina by specific plasma fibrin degradation product determination | |
| EP0298783A1 (en) | Method, device and kit for measurement of tissue plasminogen activator activity | |
| Kwon et al. | Sensing performance of protein C immuno-biosensor for biological samples and sensor minimization | |
| JP3370717B2 (ja) | キャリブレーター及びイムノアッセイにおけるその使用 | |
| JPH09302000A (ja) | 抗組織因子モノクローナル抗体及び当該モノクローナル抗体を用いた組織因子凝固活性の測定法 | |
| Nowak et al. | Levels of soluble fibrin monomer complexes in the course of myocardial infarction | |
| JPS6379900A (ja) | モノクロ−ナル抗体と検出方法 | |
| JPH07313186A (ja) | 抗ｐｉｖｋａ−ｉｉモノクロナ−ル抗体 | |
| Kazal et al. | The reactions of thrombin with fibrinogen and plasma antithrombin | |
| WO2014163170A1 (ja) | プロテインｓの活性測定試薬キット及び活性測定方法 | |
| JPS61280566A (ja) | ２’−５’−オリゴアデニル酸の免疫学的直接定量法 | |
| JPWO1991005257A1 (ja) | ヒト組織プラスミノーゲンアクチベーター・ヒトプラスミノーゲンアクチベーター複合体の免疫学的測定キツト及び測定方法 | |
| Baker et al. | Studies of 99mTc-acylplasmins as agents for thrombus detection | |
| JP2002316999A (ja) | モノクローナル抗体 |